Reading the tape
NASDAQ: INGN
Inogen, Inc.
Healthcare · Medical - Devices
Market Cap
$191.27M
52w High
$9.13
52w Low
$5.34
P/E
-8.36
Volume
37.85K
Outstanding Shares
27.32M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 0%Revenue (TTM): 3.86%FCF (TTM): -90.22%P/E: 0th pct
What changed
The stock was flat over the last year. Revenue grew 3.86% over the trailing twelve months. Operating margin moved from -12.66% to -8.66%. Free cash flow declined 90.22% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -8.66%. A decisive move in revenue — currently up 3.86% — would be the clearest signal to resolve the ambiguity.
Company profile
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
CEOKevin R. Smith
SectorHealthcare
IndustryMedical - Devices
Employees766
IPO dateFeb 14, 2014
Valuation
Forward P/E—
EV/EBITDA-35.43
Enterprise value$96.37M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth2.05%
Gross margin47.58%▲3.22%vs FY2024
Operating margin-8.66%▲31.59%vs FY2024
ROE-11.83%▲42.67%vs FY2024
Analyst consensus
RatingBuy
Target price$26.00▲271.43%
6
Buy
4
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$0.24 · Revenue est $82.36M
View